3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
1
Pulmonary Atelectasis
1
Postural Orthostatic Tachycardia Syndrome
1
Postoperative Complications
1
Pneumonia
1
Pancreatic carcinoma, familial
1
Pancreatic cancer, adult
1
Neoplasms
1
Multiple Myeloma
1
Mastocytosis
1
Lung Cancer Screening
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Esophageal Neoplasms
1
Bronchopulmonary Disease
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
durvalumab
8
Bevacizumab
7
tremelimumab
4
lenvatinib
3
atezolizumab
3
Nivolumab
3
Ipilimumab
3
fludarabine
2
Magnetic Resonance Imaging
2
Hepatectomy
2
Gemcitabine
2
Cyclophosphamide
2
Cisplatin
2
trastuzumab deruxtecan
1
toripalimab
1
ropidoxuridine
1
poly ICLC
1
pembrolizumab
1
brodalumab
1
Whole Genome Sequencing
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radionuclide Imaging
1
Pluvicto
1
Platinum
1
Paclitaxel
1
Laparoscopy
1
Immunotherapy, Adoptive
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Mass Screening
×
90 days
×
Clear all
No trials found.